DelveInsight estimates an increase in Retinitis Pigmentosa Market Size during the study period 2017–2030, from USD 237.27 million, as reported in 2017 in the 7MM.
The increase in the Retinitis pigmentosa market size, as estimated by DelveInsight, is a direct consequence of the expected launch of potential therapies, along with increasing awareness and development of novel treatments.
Retinitis pigmentosa market analysis: Therapeutic unmet needs
Retinitis pigmentosa is a heterogeneous, progressive disease, leading to worsening of the vision over time. Although, there is a significant variation in the age of onset, progression rate, the involvement of rod...
